Related Experiment Video
Updated: Jun 6, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Targeting p21 degradation locally
1Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC 27599, USA. yxiong@email.unc.edu
Abstract:
Just as the activity of many multifunctional proteins is restricted by subcellular localization, so is their regulation. In this issue of Development Cell, Starostina et al. identify an E3 ubiquitin ligase, CRL2(LRR1), for the cyclin-dependent kinase inhibitor p21 that specifically ubiquitylates cytoplasmic p21 to facilitate cell migration.
Insights
Researchers found a specific E3 ubiquitin ligase, CRL2(LRR1), that targets the cell migration protein p21 in the cytoplasm. This discovery explains how p21
Area of Science:
- Cell Biology
- Molecular Biology
- Protein Regulation
Background:
- Protein function is often controlled by where it is located within a cell.
- Regulation of protein activity is crucial for cellular processes.
Discussion:
- The study identifies CRL2(LRR1) as the E3 ubiquitin ligase responsible for targeting p21.
- CRL2(LRR1) specifically ubiquitylates p21 in the cytoplasm.
- This targeted ubiquitylation is essential for enabling cell migration.
Key Insights:
- Subcellular localization dictates protein regulation.
- CRL2(LRR1) acts as a cytoplasmic E3 ubiquitin ligase for p21.
- Cytoplasmic p21 ubiquitylation by CRL2(LRR1) promotes cell migration.
Outlook:
- Further research can explore the precise mechanisms of CRL2(LRR1) action.
- Investigating other substrates of CRL2(LRR1) may reveal broader roles.
- Understanding this pathway could offer insights into diseases involving cell migration.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

